AbbVie’s $30 Billion Senior Notes Offering

Kirkland & Ellis advised AbbVie Inc. on its private offering. AbbVie Inc. (NYSE:ABBV) has priced its private offering of senior unsecured notes in a combined aggregate…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here